Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MONODOX | Chartwell Pharmaceuticals | N-050641 RX | 1989-12-29 | 4 products, RLD |
ORACEA | Galderma | N-050805 RX | 2006-05-26 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
acticlate | New Drug Application | 2017-11-28 |
benoxyldoxy 30 kit | unapproved drug other | 2015-10-19 |
benzodox 30 kit | unapproved drug other | 2015-10-20 |
benzodox 60 kit | unapproved drug other | 2015-10-16 |
direct rx | ANDA | 2015-08-04 |
doryx | 2007-08-02 | |
doryx mpc | New Drug Application | 2025-04-03 |
doxy 100 | ANDA | 2021-02-17 |
doxy 100(tm) doxycycline | ANDA | 2024-01-30 |
doxycyclate hyclate | ANDA | 2025-02-12 |
Drug common name | Doxycycline anhydrous |
INN | doxycycline |
Description | Doxycycline is tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis. It has a role as an antibacterial drug, an antimalarial, a geroprotector, an anti-inflammatory agent and an immunomodulator. |
Classification | Small molecule |
Drug class | antibiotics (tetracycline derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 |
PDB | — |
CAS-ID | 564-25-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1433 |
ChEBI ID | 50845 |
PubChem CID | — |
DrugBank | DB00254 |
UNII ID | 334895S862 (ChemIDplus, GSRS) |